Chien‐shan Cheng

1.6k total citations
63 papers, 1.2k citations indexed

About

Chien‐shan Cheng is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Chien‐shan Cheng has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 27 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in Chien‐shan Cheng's work include Pancreatic and Hepatic Oncology Research (21 papers), Cancer Mechanisms and Therapy (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Chien‐shan Cheng is often cited by papers focused on Pancreatic and Hepatic Oncology Research (21 papers), Cancer Mechanisms and Therapy (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Chien‐shan Cheng collaborates with scholars based in China, Hong Kong and United States. Chien‐shan Cheng's co-authors include Zhen Chen, Lianyu Chen, Yibin Feng, Zhiqiang Meng, Ning Wang, Hor‐Yue Tan, Chao Qu, Huifeng Gao, Jie Chen and Jian Tang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Chien‐shan Cheng

59 papers receiving 1.2k citations

Peers

Countries citing papers authored by Chien‐shan Cheng

Since Specialization

Citations

This map shows the geographic impact of Chien‐shan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien‐shan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien‐shan Cheng more than expected).

Fields of papers citing papers by Chien‐shan Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien‐shan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien‐shan Cheng. The network helps show where Chien‐shan Cheng may publish in the future.

Co-authorship network of co-authors of Chien‐shan Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Chien‐shan Cheng. A scholar is included among the top collaborators of Chien‐shan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chien‐shan Cheng. Chien‐shan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Berberine reverses impaired adipose angiogenesis to promote beige adipogenesis by HIF-1α/PRDM16 signaling 2026 ·Phytomedicine ·Chien‐shan Cheng, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	Digital subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenocarcinoma: a phase II, open-label, randomized controlled trial comparing with intravenous chemotherapy 2024 ·BMC Cancer ·(unknown), Chien‐shan Cheng, Yehua Shen, Hao Chen, Junhua Lin, Yongqiang Hua, Lanyun Feng, Caijun Wu, Peng Wang, Zhen Chen, Zhiqiang Meng	0
3	Glutathione peroxidase 3 is essential for countering senescence in adipose remodelling by maintaining mitochondrial homeostasis 2024 ·Redox Biology ·(unknown), (unknown), Md. Ariful Islam, Wen Gu, (unknown), Chien‐shan Cheng, (unknown), Yu Xu, Hong‐Xi Xu	8
4	Novel silicene-mesoporous silica nanoparticles conjugated gemcitabine induced cellular apoptosis via upregulating NF-κB p65 nuclear translocation suppresses pancreatic cancer growth in vitro and in vivo 2024 ·Nanotechnology ·Yuhang Chen, Chien‐shan Cheng, (unknown), Shu Dong, Lianyu Chen	1
5	Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis 2023 ·Acta Pharmaceutica Sinica B ·Yau-Tuen Chan, Hor‐Yue Tan, Yuanjun Lu, Cheng Zhang, Chien‐shan Cheng, Junyu Wu, Ning Wang, Yibin Feng	29
6	Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-κB/JNK/ERK phosphorylation 2023 ·Molecular Medicine ·Juying Jiao, (unknown), Chien‐shan Cheng, Fengjiao Wang, (unknown), Zhen Chen	11
7	Evidence-Based Dampness-Heat ZHENG (Syndrome) in Cancer: Current Progress toward Establishing Relevant Animal Model with Pancreatic Tumor 2022 ·Chinese Journal of Integrative Medicine ·Juying Jiao, Chien‐shan Cheng, (unknown), Lianyu Chen, Zhen Chen	1
8	Mechanisms of pancreatic tumor suppression mediated by Xiang-lian pill: An integrated in silico exploration and experimental validation 2022 ·Journal of Ethnopharmacology ·Juying Jiao, Chien‐shan Cheng, (unknown), (unknown), (unknown), (unknown), Zhen Chen	8
9	Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression 2021 ·SHILAP Revista de lepidopterología ·Chien‐shan Cheng, Hor‐Yue Tan, Ning Wang, Lianyu Chen, Zhiqiang Meng, Zhen Chen, Yibin Feng	51
10	Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling 2021 ·BMC Cancer ·Fengjiao Wang, (unknown), Chao Qu, Lianyu Chen, Yawen Geng, Chien‐shan Cheng, Shulin Yu, (unknown), Lina Yang, Zhiqiang Meng, Zhen Chen	114
11	Volatile Anesthetics Regulate Anti-Cancer Relevant Signaling 2021 ·Frontiers in Oncology ·Jiaqiang Wang, Chien‐shan Cheng, (unknown), Shen Sun, (unknown)	10
12	Suppression of lncRNA MALAT1 by betulinic acid inhibits hepatocellular carcinoma progression by targeting IAPs via miR‐22‐3p 2020 ·SHILAP Revista de lepidopterología ·Feiyu Chen, Zhangfeng Zhong, Hor‐Yue Tan, Wei Guo, Cheng Zhang, Chien‐shan Cheng, Ning Wang, Junguo Ren, Yibin Feng	48
13	Overexpression of pyruvate dehydrogenase phosphatase 1 promotes the progression of pancreatic adenocarcinoma by regulating energy-related AMPK/mTOR signaling 2020 ·Cell & Bioscience ·Ye Li, Jia Shen, Chien‐shan Cheng, Huifeng Gao, Jiangang Zhao, Lianyu Chen	15
14	<p>Paeonol Inhibits Pancreatic Cancer Cell Migration and Invasion Through the Inhibition of TGF-β1/Smad Signaling and Epithelial-Mesenchymal-Transition</p> 2020 ·Cancer Management and Research ·Chien‐shan Cheng, Jingxian Chen, Jian Tang, Yawen Geng, Lan Zheng, Lingling Lv, Lianyu Chen, Zhen Chen	29
15	Overexpressed N-fucosylation on the cell surface driven by FUT3, 5, and 6 promotes cell motilities in metastatic pancreatic cancer cell lines 2019 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), Ke Zhang, Lianyu Chen, Chien‐shan Cheng, Hao Chen, Zhiqiang Meng, Shumin Zhou, Zhen Chen	15
16	New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin 2019 ·Cancer Cell International ·Chien‐shan Cheng, Jiaqiang Wang, Jie Chen, (unknown), Jian Tang, Huifeng Gao, Lianyu Chen, Zhen Chen, Zhiqiang Meng	83
17	Benefit from the inclusion of surgery in the treatment of patients with stage III pancreatic cancer: a propensity-adjusted, population-based SEER analysis 2018 ·Cancer Management and Research ·(unknown), Chien‐shan Cheng, Lianyu Chen, Zhen Chen	6
18	Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma 2018 ·Cellular Physiology and Biochemistry ·Hor‐Yue Tan, Ning Wang, Sha Li, Ming Hong, Wei Guo, Kwan Man, Chien‐shan Cheng, Zhen Chen, Yibin Feng	28
19	Natural Compound Methyl Protodioscin Suppresses Proliferation and Inhibits Glycolysis in Pancreatic Cancer 2018 ·Evidence-based Complementary and Alternative Medicine ·Lianyu Chen, Chien‐shan Cheng, Huifeng Gao, Ling Zhan, Fengjiao Wang, Chao Qu, Ye Li, Peng Wang, Hao Chen, Zhiqiang Meng, Luming Liu, Haifeng Chen, Zhen Chen	11
20	Targeting FASN in Breast Cancer and the Discovery of Promising Inhibitors from Natural Products Derived from Traditional Chinese Medicine 2014 ·Evidence-based Complementary and Alternative Medicine ·Chien‐shan Cheng, Zhiyu Wang, Jianping Chen	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact